Expert consensus on the monitoring of transthyretin amyloid cardiomyopathy

Transthyretin amyloid cardiomyopathy (ATTR‐CM) is a life‐threatening condition with a heterogeneous clinical presentation. The recent availability of treatment for ATTR‐CM has stimulated increased awareness of the disease and patient identification. Stratification of patients with ATTR‐CM is critica...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Eur J Heart Fail
Autores principales: Garcia‐Pavia, Pablo, Bengel, Frank, Brito, Dulce, Damy, Thibaud, Duca, Franz, Dorbala, Sharmila, Nativi‐Nicolau, Jose, Obici, Laura, Rapezzi, Claudio, Sekijima, Yoshiki, Elliott, Perry M.
Formato: Artigo
Lenguaje:Inglês
Publicado: John Wiley & Sons, Ltd. 2021
Materias:
Reviews
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC8239846/
https://ncbi.nlm.nih.gov/pubmed/33915002
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ejhf.2198
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares